Short interest in Verve Therapeutics Inc (NASDAQ:VERV) decreased during the last reporting period, falling from 14.79M to 13.25M. This put 18.69% of the company's publicly available shares short.

Short interest for Verve Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Verve Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.01M shares traded per day, it would take 6.59 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.